MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
JSPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jasper Therapeutics (JSPR) Ownership - Who owns Jasper Therapeutics?

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
22
Web
https://www.jaspertherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.33M
P/E Ratio
N/A
Total Cash
14.14M
Projected Growth
N/A
Total Debt
757K
Revenue
N/A
Risk (Beta)
2.35
Dividend Yield
N/A
Total Cash/Share
0.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
JSPR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for JSPR
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2200 Bridge Parkway
Phone
+1 650 549-1400
Employees
22
Web
https://www.jaspertherapeutics.com